Indeed, the authors demonstrated that downregulation of ER by the administration of fulvestrant in two different ER+ BC cell lines (MCF7 and ZR-75) induced downregulation of Eg5, while its administration had no impact on Eg5 expression in an ER− breast cancer cell line (MDA-231). This evidence concerns the gene KIF11 and breast cancer.